181 related articles for article (PubMed ID: 23815339)
21. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
22. Molecular Profiling in Cutaneous Melanoma.
Ji AL; Bichakjian CK; Swetter SM
J Natl Compr Canc Netw; 2016 Apr; 14(4):475-80. PubMed ID: 27059194
[TBL] [Abstract][Full Text] [Related]
23. Toward a molecular classification of melanoma.
Fecher LA; Cummings SD; Keefe MJ; Alani RM
J Clin Oncol; 2007 Apr; 25(12):1606-20. PubMed ID: 17443002
[TBL] [Abstract][Full Text] [Related]
24. Ras, Raf, and MAP kinase in melanoma.
Solus JF; Kraft S
Adv Anat Pathol; 2013 Jul; 20(4):217-26. PubMed ID: 23752084
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
Gerami P; Geraminegad P
G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
[TBL] [Abstract][Full Text] [Related]
26. Skinomics: past, present and future for diagnostic microarray studies in dermatology.
Blumenberg M
Expert Rev Mol Diagn; 2013 Nov; 13(8):885-94. PubMed ID: 24151852
[TBL] [Abstract][Full Text] [Related]
27. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers.
Abbas O; Miller DD; Bhawan J
Am J Dermatopathol; 2014 May; 36(5):363-79. PubMed ID: 24803061
[TBL] [Abstract][Full Text] [Related]
29. Molecular diagnostics in melanoma: current status and perspectives.
Dadras SS
Arch Pathol Lab Med; 2011 Jul; 135(7):860-9. PubMed ID: 21732775
[TBL] [Abstract][Full Text] [Related]
30. Molecular pathology of malignant melanoma: changing the clinical practice paradigm toward a personalized approach.
Bradish JR; Cheng L
Hum Pathol; 2014 Jul; 45(7):1315-26. PubMed ID: 24856851
[TBL] [Abstract][Full Text] [Related]
31. Clear cell melanoma: a cutaneous clear cell malignancy.
Pletneva MA; Andea A; Palanisamy N; Betz BL; Carskadon S; Wang M; Patel RM; Fullen DR; Harms PW
Arch Pathol Lab Med; 2014 Oct; 138(10):1328-36. PubMed ID: 25268196
[TBL] [Abstract][Full Text] [Related]
32. Melanoma progression, gene expression and DNA microarrays.
Hoek KS
G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
[TBL] [Abstract][Full Text] [Related]
33. TRIB2 as a biomarker for diagnosis and progression of melanoma.
Hill R; Kalathur RK; Colaço L; Brandão R; Ugurel S; Futschik M; Link W
Carcinogenesis; 2015 Apr; 36(4):469-77. PubMed ID: 25586991
[TBL] [Abstract][Full Text] [Related]
34. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
[TBL] [Abstract][Full Text] [Related]
35. [Molecular and immunohistochemical diagnostics in melanoma].
Schilling B; Griewank KG
Hautarzt; 2016 Jul; 67(7):511-8. PubMed ID: 27270408
[TBL] [Abstract][Full Text] [Related]
36. Molecular diagnostics in melanoma.
Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M
J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465
[TBL] [Abstract][Full Text] [Related]
37. Genetic progression of metastatic melanoma.
Rodolfo M; Daniotti M; Vallacchi V
Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
[TBL] [Abstract][Full Text] [Related]
38. Microphthalmia transcription factor: a specific marker for malignant melanoma.
Vachtenheim J; Borovanský J
Prague Med Rep; 2004; 105(3):318-24. PubMed ID: 15782558
[TBL] [Abstract][Full Text] [Related]
39. What genomics has taught me about melanocytic neoplasms.
Leboit PE
G Ital Dermatol Venereol; 2012 Jun; 147(3):239-49. PubMed ID: 22648325
[TBL] [Abstract][Full Text] [Related]
40. Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification.
Welinder C; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Breslin T; Rezeli M; Jansson B; Laurell T; Fehniger TE; Wieslander E; Pawlowski K; Marko-Varga G
J Proteome Res; 2014 Mar; 13(3):1315-26. PubMed ID: 24490776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]